08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
The DE OFCCP Week in Review (WIR) is a simple, fast and direct summary of relevant happenings in the...
Read More >
Credle Enterprises to Pay $340,000 to Resolve Claims of Physical and Verbal Harassment of Female Emp...
Read More >
Despite multiple challenges, many portions of the Patient Protection and Affordable Care Act (ACA) a...
Read More >
Let's dispel some myths. Force majeure clauses do not always relieve a party of its obligations. Not...
Read More >
Dangers That As A 401(k) Provider You Need To Avoid. In an instant, it can all be gone. It can tak...
Read More >
Welcome to the Great Women in Compliance Podcast, co-hosted by Lisa Fine and Mary Shirley. In this w...
Read More >